Page 39 - THE COVID-19 CHRONICLES OF MALAYSIA Embracing Ripples: Coursing Forward
P. 39
More Vaccines Approved For Use Averting Post-Flood Diseases
6 January 2022: A Longer Shelf Life MOH gives conditional approval for the use of 6 January 2022: Large Scale PPVs Coming Soon Four PPVs, namely PPV World Trade
Comirnaty Solution for Injection, a ready-to-use vaccine with a longer shelf life. § Centre (WTC) in Kuala Lumpur, PPV Axiata Arena in Bukit Jalil, PPV IDCC in Shah Alam
and PPV Soka Gakkai in Klang, will be operating starting 15 Jan to amplify booster
vaccination capacity. §
Source: MOH COVID-19 §, §
Convidecia® Approved as a Homogenous Booster Convidecia® Recombinant Novel
Coronavirus Vaccine (Adenovirus Type 5 Vector) Injection receives conditional
approval as booster for adults who have completed their vaccination with the same
vaccine 3 to 6 months prior. §
Source: JKJAV Twitter §
Source: NPRA §
9
